Advertisement

Nebenschilddrüse

  • M. J. Seibel
  • E. Blind
  • T. Schilling
  • H. W. Woitge

Zusammenfassung

Der Serumkalziumspiegel wird normalerweise in engen Grenzen gehalten, um die ungestörte Gewebefunktion zu gewährleisten. Regelgröße ist hierbei der Spiegel des freien Kalziums (Normalwert: 1,1-1,3 mmol/l), das etwa 50% des Gesamtserumkalziums (Normalwert: 2,2-2,65 mmol/l) ausmacht. Etwa 40 % des Gesamtserumkalziums sind an Albumin gebunden, während etwa 10% als Phosphatoder Zitratsalzkomplexe vorliegen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur zu Abschn. 10.1

  1. Blind E, Nissenson R.A., Strewler G.J. (1995) Parathyroid hormone-related protein. In: Becker K (ed) Principles and practice of endocrinology and metabolism. Lippincott, Philadelphia, pp 467–474Google Scholar
  2. Blind E., Schmidt-Gayk H., Scharia S., Flentje D., Fischer S., Göhring U., Hitzler W. (1988) Two-site assay of intact parathyroid hormone in the investigation of primary hyperparat-hyroidism and other disorders of calcium metabolism compared with amidregion assay. J Clin Endocrinol Metab 67: 353–360PubMedCrossRefGoogle Scholar
  3. Brown E.M., Gamba G., Riccardi D. et al. (1993) Cloning and characterization of an extracellular Ca(2 + )-sensing receptor from bovine parathyroid. Nature 366: 575–580PubMedCrossRefGoogle Scholar
  4. Brown E.M., Pollak M., Seidman C.E., Seidman J.G., Chou Y.H., Riccardi D., Hebert S.C. (1995) Calcium-ion-sensing cell-surface receptors. N Engl J Med 333: 234–240PubMedCrossRefGoogle Scholar
  5. Jüppner H., Abou-Samra A.B., Freeman M. et al. (1991) A G-protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254: 1024–1026PubMedCrossRefGoogle Scholar
  6. Schipani E., Langmann C., Parfitt A. et al. (1996) Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia. N Engl J Med 335: 708–714PubMedCrossRefGoogle Scholar
  7. Schmidt-Gayk H, Thomas L (1992) Mineralhaushalt und Nebenschilddrüse. In: Thomas L (ed) Labor und Diagnose. Medizinische Verlagsgesellschaft, Marburg, S 342–386Google Scholar
  8. Segre G.V., Goldring S.R. (1993) Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glacagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family. Trends Endocrinol Metab 4: 309–314PubMedCrossRefGoogle Scholar

Literatur zu Abschn. 10.2

  1. Farfel Z., Brothers V.M., Brickman A.S., Conte F., Neer R., Bourne H.R. (1981) Pseudohypoparathyroidism: Inheritance of deficient receptor-cyclase coupling activity. Proc Natl Acad Sci USA 78: 3098–3102PubMedCrossRefGoogle Scholar
  2. Levine M.A., Ahn T.G., Klupt S.F. et al. (1988) Genetic deficiency of the alpha subunit of the guanine nucieotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA 85: 617–621PubMedCrossRefGoogle Scholar
  3. Müller W., Peter H.H., Wilken M. et al. (1988) The DiGeorge syndrome: I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 147: 496–502PubMedCrossRefGoogle Scholar
  4. Patten J.L., Johns D.R., Valle D. et al. (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy. N Engl J Med 322: 1412–1419PubMedCrossRefGoogle Scholar
  5. Schilling T., Ziegler R. (1996) Diagnostik und Therapie des Hypoparathyreoidismus. Dtsch Med Wochenschr 121: 841–844Google Scholar
  6. Schilling T., Ziegler R. (1997) Current therapy of hypoparathyroidism-a survey of german endocrinology centers. Exp Clin Endocrinol Diabetes 105: 237–241PubMedCrossRefGoogle Scholar
  7. Ziegler R., Minne H., Raue F., Paar G., Delling G. (1975) Beobachtungen zur Vitamin-D-und Dihydrotachysterin-Vergiftung. Dtsch Med Wochensehr 100: 415–423CrossRefGoogle Scholar

Literatur zu Abschn. 10.3 und 10.4

  1. Attie M.F. (1989) Treatment ofhypercalcemia. Endocrinol Metab Clin North Am 18: 807–828PubMedGoogle Scholar
  2. Bilezikian J.P. (1992) Managment of acute hypercalcemia. N Engl J Med 326: 1196–1203PubMedCrossRefGoogle Scholar
  3. Bilezikian J.P., Silverberg S.I., Gartenberg F., Kim T.S., Jacobs T.P., Siris E.S., Shane E. (1994) Clinical presentation of primary hyperparathyroidism. In: Bilezikian J.P., Marcus R., Levine M.A. (eds) The parathyroids. Raven, New York, pp 457–470Google Scholar
  4. Bilezikian J.P. (1996) Primary hyperparathyroidism. In: Favus J.M. (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd edn, Lippincott & Rayen, Philadelphia, pp 181–186Google Scholar
  5. Coburn J.W. (1989) Control of serum phosphorus in uremia. N Engl J Med 320: 1140–1142PubMedCrossRefGoogle Scholar
  6. Consensus Development Conferenee Panel (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism. Consensus Development Conference Statement. Ann Intern Med 114: 593–597CrossRefGoogle Scholar
  7. Doppman J.L. (1996) Preoperative localization of parathyroid tissue in primary hyperparathyroidism. In: Favus J.M. (ed) Primer on the metabolic bone diseases and dis orders of mineral metabolism. 3rd edn, Lippincott & Raven, Philadelphia, pp 553–556Google Scholar
  8. Drings P. (1974) Normokalzämischer primärer Hyperparathyreoidismus. Münchner Med Wochenschr 116: 1107Google Scholar
  9. Heath H. 3rd, Hodgson S.F., Kennedy M.A. (1980) Primary hyperparathyroidism: Incidence, morbidity, and potential economic impact in a community. N Engl J Med 302(4):189–193PubMedCrossRefGoogle Scholar
  10. Heath H. 3rd (1996) Familial hyperparathyroid syndroms. In: Favus J.M. (ed) Primer on the metabolic bone diseases and dis orders of mineral metabolism. 3rd edn, Lippincott & Raven, Philadelphia, pp 187–189Google Scholar
  11. Hruska K.A., Teitelbaum S.L. (1995) Renal osteodystrophy. N Engl J Med 333: 166–174PubMedCrossRefGoogle Scholar
  12. Jockenhövel F., Reinwein D. (1994) Asymptomatischer primärer Hyperparathyreoidismus:Behandeln oder beobachten? Dtseh Med Wochenschr 119: 967–973CrossRefGoogle Scholar
  13. Kleerekoper M., Bilezikian J.P. (1994) Parathyroidectomy for non-traditional features of primary hyperparathyroidism. Am J Med 96: 99–100PubMedCrossRefGoogle Scholar
  14. Kleerekorer M. (1996) Clinical course of primary hyperparathyroldlsm. In: Favus J.M. (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd edn Lippincott & Raven, Philadelphia, pp 171–478Google Scholar
  15. Mitchell B.K., Kinder B.K., Cornelius E., Steward A.F. (1995) Primary hyperparathyroidism: Preoperative localization using technetium sestamibi scanning. J Clin Endocrinol Metab 80(1):7–10PubMedCrossRefGoogle Scholar
  16. Nussbaum S.R. (1993) Pathophysiologiy and management of severe hypercalcemia. Endocrinol Metab Clin North Am 22: 343–362PubMedGoogle Scholar
  17. Parisien M., Silverberg S.J., Shane E., Dempster D.W., Bilezikian J.P. (1990) Bone disease in primary hyperparathyroidism. Endocrinol Metab Clin North Am 19(1):19–34PubMedGoogle Scholar
  18. Payne R.B., Carver M.E., Morgan D.B. (1979) Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 32(1):56–60PubMedCrossRefGoogle Scholar
  19. Pollak M.R. et al. (1993) Mutations in the human Ca++ sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297–1303PubMedCrossRefGoogle Scholar
  20. Roe S.M., Bums R.P., Graham L.D., Brock W.B., Russell W.L. (1994) Cost-effectiveness of preoperative localization studies in primary hyperparathyroid disease. Ann Surg 219(5):582–586PubMedGoogle Scholar
  21. Schmidt-Gayk H. (1997) Störungen der Kalzium-und Phosphathomöostase. In: Seibel M.J., Stracke H. (Hrsg) Metabolische Osteopathien. Schattauer, Stuttgart, p 243–275Google Scholar
  22. Shane E. (1996) Hypercalcemia:Pathogenesis, Clinical manifestations, differential diagnosis and managment. In: Favus J.M. (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd edn, Lippincott & Raven, Philadelphia, pp 177–181Google Scholar
  23. Ziegler R., Breckwoldt W., Grußendorf M., Kruse K. (1993) Nebenschilddrüsen und Calciumhomöostase In: Deutsche Gesellschaft für Endokrinologie (Hrsg) Rationelle Diagnostik in der Endokrinologie. Thieme, Stuttgart, S 79–103Google Scholar
  24. Ziegler R., Hesch R.D., Kruse K., Raue F., Rothmund M. (1997) Nebenschilddrüsen und Calciumhomöostase (einschließlich Osteopthien) In: Deutsche Gesellschaft für Endokrinologie (Hrsg) Rationelle Diagnostik in der Endokrinologie. Thieme, Stuttgart, S 103–148Google Scholar

Literatur zu Abschn. 10.5

  1. Bartl R. (1992) Entstehung und histologische Diagnose von Knochenmetastasen. In: Wüster C.h., Ziegler R. (Hrsg) Knochenmetastasen: Pathophysiologie, Diagnostik und Therapie. Zuckschwerdt, München, pp 1–15Google Scholar
  2. Bilezikian J.P. (1992) Management of acute hypercalcemia. N Engl J Med 326: 1196–1203PubMedCrossRefGoogle Scholar
  3. Burtis W.J., Brady T.G., Orloff J.J. et al. (1980) Immunochemical characterization of circulating PTH-related pro tein in patients with humoral hypercalcemia of malignancy. N Engl J Med 322: 1106–1112CrossRefGoogle Scholar
  4. Diel I.J. (1997) Tumorassoziierte Störungen des Knochen-und Mineralstoffwechsels. In: Seibel M.I., Stracke H. (Hrsg) Metabolische Osteopathien. Schattauer, Stuttgart, pp 276–287Google Scholar
  5. Galasko C.S.B. (1981) The anatomy and pathways of skeletal metastases. In: Weiß L., Gilbert A.H. (eds) Bone metastasis. Hall, Boston, pp 49–63Google Scholar
  6. Garrett R.I., Durie B.G.M., Nedwin G.E. et al. (1987) Production of the bone resorbing cytokine lymphotoxin by cultured human myeloma cells. N Engl J Med 317: 526–532PubMedCrossRefGoogle Scholar
  7. Harinck H.I.J., Bijvoet O.L.M., Platingh A.S.T. (1987) Role of bone and kidney in tumor-associated hypercalcemia and ist treatment with Bisphosphonate and sodium chloride. Am J Med 82: 1113–1142.CrossRefGoogle Scholar
  8. Mundy G.R., Martin T.J. (1982) The hypercalcemia of malignancy: pathogenesis and treatment. Metabolism 31: 1247–1277PubMedCrossRefGoogle Scholar
  9. Ralston S.H., Gallacher S.I., Patel U. et al. (1990) Cancer-associated hypercalcemia:morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 112: 499–504PubMedCrossRefGoogle Scholar
  10. Stewart A.F., Horst R., Deftos L.J. et al. (1980) Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and non-humoral groups. N Engl J Med 303: 1377–1383PubMedCrossRefGoogle Scholar
  11. Zipf A., Seibel M.J. (1992) Biochemische Labordiagnostik bei Knochenmetastasen. In: Wüster C.h., Ziegler R. (eds) Knochenmetastasen: Pathophysiologie, Diagnostik und Therapie. Zuckschwerdt, München, pp 16–33)Google Scholar

Literatur zu Abschn. 10.6

  1. Attie M.F. (1989) Treatment of hypercalcemia. Endocrinol Metab Clin North Am 18: 807–828PubMedGoogle Scholar
  2. Bilezikian J.P. (1992) Managment of acute hypercalcemia. N Engl J Med 326: 1196–1203PubMedCrossRefGoogle Scholar
  3. Nussbaum S.R. (1993) Pathophysiologiy and management of severe hypercalcemia. Endocrinol Metab Clin North Am 22: 343–362PubMedGoogle Scholar
  4. Schmidt-Gayk H. (1997) Störungen der Kalzium-und Phosphathomöostase. In: Seibel M.I., Stracke H. (Hrsg) Metabolische Osteopathien. Schattauer, Stuttgart, S 243–275Google Scholar
  5. Shane E. (1996) Hypercalcemia: Pathogenesis, clinical manifestations, differential diagnosis and managment. In: Favus J.M. (ed) Primeron the metabolic bone diseases and disorders of mineral metabolism. 3rd edn, Lippincott & Raven, Philadelphia, pp 177–181Google Scholar
  6. Ziegler R., Breckwoldt W., Grußendorf M., Kruse K. (1993) Nebenschilddrüsen und Calciumhomöostase In: Deutsche Gesellschaft für Endokrinologie (Hrsg) Rationelle Diagnostik in der Endokrinologie. Thieme, Stuttgart, S 79–103Google Scholar
  7. Ziegler R., Hesch R.D., Kruse K., Raue F., Rothmund M. (1997) Nebenschilddrüsen und Calciumhomöostase (einschließlich Osteopthien) In: Deutsche Gesellschaft für Endokrinologie (Hrsg) Rationelle Diagnostik in der Endokrinologie. Thieme, Stuttgart, S 103–148Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • M. J. Seibel
  • E. Blind
  • T. Schilling
  • H. W. Woitge

There are no affiliations available

Personalised recommendations